India

OrbiMed lines up $551M gamble on China, India biotech sectors
OrbiMed lines up $551M gamble on China, India biotech sectors
Endpoints
OrbiMed
China
India
biotech
venture capital
Flag link:
With U.S. Generic Drug Market in Chaos, Indian Upstarts Rise
With U.S. Generic Drug Market in Chaos, Indian Upstarts Rise
Bloomberg
generics
India
Flag link:
Pfizer Wins Indian Patent on Prevnar 13 Vaccine
Pfizer Wins Indian Patent on Prevnar 13 Vaccine
RAPS.org
Pfizer
India
Prevnar 13
vaccine
patents
Flag link:
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
GoInPharma
Intas
India
M&A
Teva Pharmaceutical
Europe
Women's Health
oncology
pain management
Flag link:
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
Mass Device
FDA
India
clinical trials
Flag link:
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
FDA Voice
FDA
India
clinical trials
Flag link:
Indian drugmaker stages worker strike to avoid FDA inspection
Indian drugmaker stages worker strike to avoid FDA inspection
BioPharma Dive
India
FDA
inspection
warning letter
Flag link:
The Billionaire And The Drug Price-Fixing Scandal
The Billionaire And The Drug Price-Fixing Scandal
Forbes
price fixing
India
Heritage Pharmaceuticals
Emcure
Flag link:
FDA jumps on another Mylan plant in India, slapping it with a warning letter
FDA jumps on another Mylan plant in India, slapping it with a warning letter
Fierce Pharma
FDA
drug manufacturing
India
Mylan Labs
Flag link:
India Authorized Agent Role Changes under New Medical Device Rules
India Authorized Agent Role Changes under New Medical Device Rules
Emergo
India
devices
Flag link:
As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters
As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters
Fierce Pharma
Bayer
intellectual property
India
exporting
Xarelto
Nexavar
Flag link:
India wants to sell low-cost drugs in Trump’s America, but quality questions persist
India wants to sell low-cost drugs in Trump’s America, but quality questions persist
Fierce Pharma
India
drug manufacturing
Flag link:
Abbott denies reports it will bail on India’s high-end stent market
Abbott denies reports it will bail on India’s high-end stent market
Mass Device
Abbott Labs
India
coronary stents
devices
Flag link:
New medical device rules from Indian regulators
New medical device rules from Indian regulators
Mass Device
devices
India
regulatory
Flag link:
India is now classifying dozens of drug makers as high-risk
India is now classifying dozens of drug makers as high-risk
Stat/Pharmalot
India
compliance
Flag link:
A day in the life of a drug rep in India
Flag link:
Piramal picks up J&J drugs in strategic move
Piramal picks up J&J drugs in strategic move
BioPharma Dive
Piramal Healthcare
India
JNJ
Sublimaze
Sufenta
Dipidolor
Rapifen
Hypnomidate
Flag link:
Dr Reddy's and Amgen broaden marketing collaboration
Dr Reddy's and Amgen broaden marketing collaboration
BioPharma Dive
Amgen
Dr Reddy's
India
Xgeva
Prolia
Vectibix
Flag link:
Sun Pharma's ex-Ranbaxy sales reps threaten all-India strike against new policies
Sun Pharma's ex-Ranbaxy sales reps threaten all-India strike against new policies
Fierce Pharma
Sun Pharma
Ranbaxy
India
drug reps
Flag link:
FDA renews ban on Indian drugmaker after fresh violations
FDA renews ban on Indian drugmaker after fresh violations
BioPharma Dive
FDA
India
Pan Drugs
drug manufacturing
Flag link: